Metabolic consequences of erastin-induced ferroptosis in human ovarian cancer cells: an untargeted metabolomics study

Kaylie I. Kirkwood-Donelson, Alan K. Jarmusch, Carl D. Bortner, Bruce Alex Merrick, Birandra K. Sinha · 2025

Read Metabolic consequences of erastin-induced ferroptosis in human ovarian cancer cells: an untargeted metabolomics study by Kaylie I. Kirkwood-Donelson, Alan K. Jarmusch, Carl D. Bortner, Bruce Alex Merrick, Birandra K. Sinha (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11788483.txt.

Description

Kaylie Kirkwood-Donelson and co-authors chart the chemical fallout when a drug forces ovarian cancer cells into a rust-like death, in a paper whose text dates it to 2024. The drug, erastin, triggers ferroptosis, an iron-driven death fuelled by oxidative damage, attractive because resistant cancers still succumb. The team treated two ovarian cancer lines, one of them drug-resistant, and profiled hundreds of small molecules inside the cells.

Both lines drained their glutathione and cysteine, the cell's main antioxidant reserves, and built up ophthalmate, a known stress marker. Taurine, another natural antioxidant, fell too. Because both the sensitive and resistant lines reacted alike, the shared chemical signature may serve as a biomarker that ferroptosis is truly under way. Such markers would help clinicians judge whether the new death pathway is being hit in patients.

Catalog record

CREATORKaylie I. Kirkwood-Donelson, Alan K. Jarmusch, Carl D. Bortner, Bruce Alex Merrick, Birandra K. Sinha
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11788483

Browse the full library · About the Tower of Babel